|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 1050 K STREET, NW, #800 |
Address2 | |
City | WASHINGTON |
State | DC |
Zip Code | 20001 |
Country | USA |
3. Principal place of business (if different than line 2)
City | WASHINGTON |
State | DC |
Zip Code | 20001 |
Country | USA |
|
5. Senate ID# 16293-12
|
||||||||
|
6. House ID# 314610000
|
TYPE OF REPORT | 8. Year | 2008 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date | |
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: Sarah J. Walsh, Vice President, Federal Government Relations Tax & Pharmaceuticals |
Date | 01/16/2009 |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code CPT
16. Specific lobbying issues
H.R. 1908 Patent Reform Act of 2007
S. 1145 Patent Reform Act of 2007
S. 3600 Patent Reform Act of 2008
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Janie |
Kinney |
|
|
|
Sarah |
Walsh |
|
|
|
Patrick |
McLain |
|
|
|
William |
Schuyler |
|
|
|
Kimberly |
Williams |
|
|
|
Mary Catherine |
Mantho |
|
|
|
Gary |
Heimberg |
|
|
|
Jeffrey |
Ringer |
|
Legislative Director - Rep. Mary Fallin 2007-08 |
|
Jeffrey |
Ringer |
|
Sr. Legislative Asst. - Sen. Conrad Burns 2005-07 |
|
Jeffrey |
Ringer |
|
Legislative Asst.-Sen. Elizabeth Dole 2002-05 |
|
John |
Herzog |
|
|
|
John |
Herzog |
|
|
|
John |
Herzog |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
S. 242 Pharmaceutical Market Access and Drug Safety Act of 2007
H.R. 380 Pharmaceutical Market Access and Drug Safety Act of 2007
H.R. 4854 False Claims Act Correction Act of 2007
S. 2029 False Claims Act Correction Act of 2007
H.R. 4703 Vaccine Shortage Preparedness Act of 2008
S. 2467 Vaccine Shortage Preparedness Act of 2008
S. 2476 Improved Vaccines Supply Act
H.R. 3944 National Hepatitis B Act
H.R. 5884 Sunshine in Litigation Act of 2008
S. 2449 Sunshine in Litigation Act of 2007
H.R. 5605 Physician Payments Sunshine Act of 2008
S. 2029 Physician Payments Sunshine Act of 2007
H.R. 3610 Food and Drug Import Safety Act of 2007
S. 3409 Drug and Device Accountability Act of 2008
H.R. 6381 Medical Device Safety Act of 2008
S. 3398 Medical Device Safety Act of 2008
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Janie |
Kinney |
|
|
|
Sarah |
Walsh |
|
|
|
Patrick |
McLain |
|
|
|
William |
Schuyler |
|
|
|
Kimberly |
Williams |
|
|
|
Mary Catherine |
Mantho |
|
|
|
Gary |
Heimberg |
|
|
|
Jeffery |
Ringer |
|
Legislative Director - Rep. Mary Fallin 2007-08 |
|
Jeffrey |
Ringer |
|
Sr. Legislative Asst. - Sen. Conrad Burns 2005-07 |
|
Jeffrey |
Ringer |
|
Legislative Asst.-Sen. Elizabeth Dole 2002-05 |
|
John |
Herzog |
|
|
|
John |
Herzog |
|
|
|
John |
Herzog |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MED
16. Specific lobbying issues
S. 623 Access to Lifesaving Medicine Act
H.R. 1038 Access to Lifesaving Medicine Act
H.R. 1956 Patient Protection and Innovative Biologic Medicine Act of 2007
S. 1695 Biologics Price Competition and Innovation Act of 2007
S. 1505 Affordable Biologics for Consumer Act
H.R. 5629 Pathway for Biosimilars Act
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Janie |
Kinney |
|
|
|
Sarah |
Walsh |
|
|
|
Patrick |
McLain |
|
|
|
William |
Schuyler |
|
|
|
Kimberly |
Williams |
|
|
|
Mary Catherine |
Mantho |
|
|
|
Gary |
Heimberg |
|
|
|
Jeffrey |
Ringer |
|
Legislative Director - Rep. Mary Fallin 2007-08 |
|
Jeffrey |
Ringer |
|
Sr. Legislative Asst.- Sen. Conrad Burns 2005-07 |
|
Jeffrey |
Ringer |
|
Legislative Asst.-Sen. Elizabeth Dole 2002-05 |
|
John |
Herzog |
|
|
|
John |
Herzog |
|
|
|
John |
Herzog |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
H.R. 4 Medicare Prescription Drug Price Negotiation Act of 2007
S. 3 Medicare Prescription Drug Price Negotiation Act of 2007
H.R. 3162 Children's Health and Medicare Protection Act of 2007
S. 1224 SCHIP Reauthorization Act of 2007
S. 2532 Medicare, Medicaid, and SCHIP Indian Health Care Improvement Act of 2007
S. 2086 SCHIP Extension Act of 2007
H.R. 3176 SCHIP Reauthorization and Reform Act of 2007
H.R. 6331 Medicare Improvements for Patient and Providers Act of 2008
S. 3101 Medicare Improvements for Patients and Providers Act of 2008
H.R. 3043 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2008- pertaining to AIDS & HIV treatments.
S. 3230 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2009 - pertaining to AIDS & HIV treatments.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Health & Human Services - Dept of (HHS)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Janie |
Kinney |
|
|
|
Sarah |
Walsh |
|
|
|
Patrick |
McLain |
|
|
|
William |
Schuyler |
|
|
|
Kimberly |
Williams |
|
|
|
Mary Catherine |
Mantho |
|
|
|
Gary |
Heimberg |
|
|
|
Jeffrey |
Ringer |
|
Legislative Director- Rep. Mary Fallin 2007-08 |
|
Jeffrey |
Ringer |
|
Sr. Legislative Asst.- Sen. Conrad Burns 2005-07 |
|
Jeffrey |
Ringer |
|
Legislative Asst.-Sen. Elizabeth Dole 2002-05 |
|
John |
Herzog |
|
|
|
John |
Herzog |
|
|
|
John |
Herzog |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TAX
16. Specific lobbying issues
H.R. 2138 Investment in America Act of 2007 - to extend the R&D tax credit.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Janie |
Kinney |
|
|
|
Sarah |
Walsh |
|
|
|
Patrick |
McLain |
|
|
|
William |
Schuyler |
|
|
|
Kimberly |
Williams |
|
|
|
Mary Catherine |
Mantho |
|
|
|
Gary |
Heimberg |
|
|
|
Jeffrey |
Ringer |
|
Legislative Director - Rep. Mary Fallin 2007-08 |
|
Jeffrey |
Ringer |
|
Sr. Legislative Asst.- Sen. Conrad Burns 2005-07 |
|
Jeffrey |
Ringer |
|
Legislative Asst.- Sen. Elizabeth Dole 2002-05 |
|
John |
Herzog |
|
|
|
John |
Herzog |
|
|
|
John |
Herzog |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TRD
16. Specific lobbying issues
U.S. Korea Free Trade Agreement - provisions pertaining to the protection of intellectual property.
U.S. Panama Free Trade Agreement - provisions pertaining to the protection of intellectual property.
H.R. 3688 - U.S. Peru Free Trade Agreement - provisions pertaining to the protection of intellectual property.
U.S. Columbia Free Trade Agreement - provisions pertaining to the protection of intellectual property.
H.R. 3866 Small Business Programs Act of 2007
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Janie |
Kinney |
|
|
|
Sarah |
Walsh |
|
|
|
Patrick |
McLain |
|
|
|
William |
Schuyler |
|
|
|
Kimberly |
Williams |
|
|
|
Mary Catherine |
Mantho |
|
|
|
Gary |
Heimberg |
|
|
|
Jeffrey |
Ringer |
|
Legislative Director - Rep. Mary Fallin 2007-08 |
|
Jeffrey |
Ringer |
|
Sr. Legislative Asst. - Sen. Conrad Burns 2005-07 |
|
Jeffrey |
Ringer |
|
Legislative Asst.- Sen. Elizabeth Dole 2002-05 |
|
John |
Herzog |
|
|
|
John |
Herzog |
|
|
|
John |
Herzog |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address | 1050 K Street, NW, Suite 800 |
||||||
City | WASHINGTON |
State | DC |
Zip Code | 20001 |
Country | USA |
21. Client new principal place of business (if different than line 20)
City | WASHINGTON |
State | DC |
Zip Code | 20001 |
Country | USA |
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
5 |
|
||||||
2 |
|
6 |
|
||||||
3 |
|
7 |
|
||||||
4 |
|
8 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 3 | 5 |
2 | 4 | 6 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 5 | 9 |
2 | 6 | 10 |
3 | 7 | 11 |
4 | 8 | 12 |